Search filters

Authors whose works are in public domain in at least one jusrisdiction

List of works by David B Solit

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

scientific article published in 2022

AKT mutant allele-specific activation dictates pharmacologic sensitivities

scientific article published on 19 April 2022

Accelerating precision medicine in metastatic prostate cancer

scientific article published on 17 November 2020

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

scientific article published on 25 November 2019

Aggressive Hematopoietic Malignancy Characterized by Biallelic Loss of SMARCB1

scientific article published on 28 October 2020

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

scientific article published on 26 October 2020

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

scientific article published in 2022

Clinical cancer genomic profiling

scientific article published on 24 March 2021

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

scientific article published on 30 January 2017

Genetic predictors of MEK dependence in non-small cell lung cancer

scientific article

Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial Carcinoma

scientific article published on 14 January 2016

Genomic Characterization of Upper Tract Urothelial Carcinoma

scientific article

Genomic characterization of response to chemoradiation in urothelial bladder cancer

scientific article

Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder

scientific article

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

scientific article published on 04 September 2011

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants

scientific article published on 25 November 2019

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

scientific article published on 07 April 2021

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

scientific article published in 2022

JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors

scientific article published on 29 March 2016

MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking

scientific article

Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression

scientific article published on 17 November 2015

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

scientific article published on 24 April 2020

Molecular classification and diagnostics of upper urinary tract urothelial carcinoma

scientific article published on 01 June 2021

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2)

scientific article published on 09 October 2018

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

scientific article published on 2 June 2017

Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma

scientific article published on July 2008

PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer

scientific article published on 23 September 2019

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

scientific article

Pilot study of 68Ga-DOTA-F(ab')2-trastuzumab in patients with breast cancer.

scientific article published on December 2013

Pilot trial of unlabeled and indium-111-labeled anti-prostate-specific membrane antigen antibody J591 for castrate metastatic prostate cancer.

scientific article published on October 2005

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials

scientific article

Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma

scientific article published on 9 August 2017

Protein-altering germline mutations implicate novel genes related to lung cancer development

scientific article published on 11 May 2020

Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies

scientific article published on 29 November 2009

Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer ⬇️

scientific article published on 27 April 2016

The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

scientific journal article

Therapeutic Implications of Germline Testing in Patients With Advanced Cancers

scientific article published on 16 June 2021

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

Paulina is supported by:

About Paulina

Help